506943 Stock Overview
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
My Notes
Capture your thoughts, links and company narrative
J. B. Chemicals & Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,742.80 |
| 52 Week High | ₹2,029.00 |
| 52 Week Low | ₹1,473.95 |
| Beta | 0.0076 |
| 1 Month Change | -5.52% |
| 3 Month Change | -11.16% |
| 1 Year Change | 3.53% |
| 3 Year Change | 91.05% |
| 5 Year Change | 534.78% |
| Change since IPO | 68,379.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506943 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.4% | -3.4% | -1.4% |
| 1Y | 3.5% | 18.6% | 5.8% |
Return vs Industry: 506943 underperformed the Indian Pharmaceuticals industry which returned 18.6% over the past year.
Return vs Market: 506943 underperformed the Indian Market which returned 5.8% over the past year.
Price Volatility
| 506943 volatility | |
|---|---|
| 506943 Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 506943 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 506943's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 5,311 | Nikhil Chopra | www.jbpharma.com |
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms.
J. B. Chemicals & Pharmaceuticals Limited Fundamentals Summary
| 506943 fundamental statistics | |
|---|---|
| Market cap | ₹271.19b |
| Earnings (TTM) | ₹6.11b |
| Revenue (TTM) | ₹37.11b |
44.4x
P/E Ratio7.3x
P/S RatioIs 506943 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506943 income statement (TTM) | |
|---|---|
| Revenue | ₹37.11b |
| Cost of Revenue | ₹12.84b |
| Gross Profit | ₹24.27b |
| Other Expenses | ₹18.16b |
| Earnings | ₹6.11b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 04, 2025
| Earnings per share (EPS) | 39.27 |
| Gross Margin | 65.40% |
| Net Profit Margin | 16.47% |
| Debt/Equity Ratio | 2.5% |
How did 506943 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield17%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 17:48 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
J. B. Chemicals & Pharmaceuticals Limited is covered by 29 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Antique Stockbroking Ltd. |
| null null | Asian Markets Securities Private Limited |
| Vijayaraghavan Swaminathan | Avendus Spark |